IDEXX Laboratories Inc (IDXX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, IDEXX Laboratories Inc (IDXX) has a cash flow conversion efficiency ratio of 0.222x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($355.76 Million) by net assets ($1.61 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
IDEXX Laboratories Inc - Cash Flow Conversion Efficiency Trend (1991–2025)
This chart illustrates how IDEXX Laboratories Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read IDEXX Laboratories Inc debt and liabilities for a breakdown of total debt and financial obligations.
IDEXX Laboratories Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of IDEXX Laboratories Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
ArcelorMittal SA ADR
NYSE:MT
|
0.053x |
|
Occidental Petroleum Corporation
NYSE:OXY
|
0.076x |
|
BASF SE
XETRA:BAS
|
0.040x |
|
KBC GROEP N.V. ADR
F:KDB0
|
N/A |
|
Shanghai Pudong Development Bank Co Ltd
SHG:600000
|
0.255x |
|
RIO Tinto Ltd
AU:RIO
|
0.151x |
|
Itaú Unibanco Holding S.A
F:BVXB
|
-0.202x |
|
Ciena Corp
NYSE:CIEN
|
0.082x |
Annual Cash Flow Conversion Efficiency for IDEXX Laboratories Inc (1991–2025)
The table below shows the annual cash flow conversion efficiency of IDEXX Laboratories Inc from 1991 to 2025. For the full company profile with market capitalisation and key ratios, see IDEXX Laboratories Inc stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $1.61 Billion | $1.18 Billion | 0.736x | +26.41% |
| 2024-12-31 | $1.60 Billion | $929.00 Million | 0.582x | -4.64% |
| 2023-12-31 | $1.48 Billion | $906.51 Million | 0.611x | -31.54% |
| 2022-12-31 | $608.74 Million | $542.98 Million | 0.892x | -18.54% |
| 2021-12-31 | $689.99 Million | $755.55 Million | 1.095x | +6.92% |
| 2020-12-31 | $632.79 Million | $648.06 Million | 1.024x | -60.34% |
| 2019-12-31 | $177.82 Million | $459.16 Million | 2.582x | +105.96% |
| 2018-12-31 | $-9.23 Million | $400.08 Million | -43.332x | -525.03% |
| 2017-12-31 | $-53.84 Million | $373.28 Million | -6.933x | -124.23% |
| 2016-12-31 | $-108.21 Million | $334.57 Million | -3.092x | -20.03% |
| 2015-12-31 | $-84.00 Million | $216.36 Million | -2.576x | -228.43% |
| 2014-12-31 | $117.59 Million | $235.85 Million | 2.006x | +322.52% |
| 2013-12-31 | $518.21 Million | $246.00 Million | 0.475x | +31.16% |
| 2012-12-31 | $636.26 Million | $230.28 Million | 0.362x | -11.51% |
| 2011-12-31 | $539.59 Million | $220.70 Million | 0.409x | +31.34% |
| 2010-12-31 | $574.28 Million | $178.83 Million | 0.311x | -7.76% |
| 2009-12-31 | $514.58 Million | $173.72 Million | 0.338x | +3.20% |
| 2008-12-31 | $438.19 Million | $143.34 Million | 0.327x | +6.11% |
| 2007-12-31 | $438.32 Million | $135.12 Million | 0.308x | +15.05% |
| 2006-12-31 | $409.86 Million | $109.83 Million | 0.268x | -15.09% |
| 2005-12-31 | $369.31 Million | $116.55 Million | 0.316x | +31.58% |
| 2004-12-31 | $397.66 Million | $95.38 Million | 0.240x | -15.39% |
| 2003-12-31 | $413.29 Million | $117.16 Million | 0.283x | -6.39% |
| 2002-12-31 | $340.97 Million | $103.25 Million | 0.303x | +97.07% |
| 2001-12-31 | $301.73 Million | $46.36 Million | 0.154x | +42.42% |
| 2000-12-31 | $261.75 Million | $28.24 Million | 0.108x | -41.69% |
| 1999-12-31 | $284.30 Million | $52.60 Million | 0.185x | +23.53% |
| 1998-12-31 | $307.80 Million | $46.10 Million | 0.150x | +235.82% |
| 1997-12-31 | $302.70 Million | $13.50 Million | 0.045x | +79.90% |
| 1996-12-31 | $322.70 Million | $8.00 Million | 0.025x | +1.75% |
| 1995-12-31 | $279.10 Million | $6.80 Million | 0.024x | -83.57% |
| 1994-12-31 | $99.80 Million | $14.80 Million | 0.148x | +67.54% |
| 1993-12-31 | $83.60 Million | $7.40 Million | 0.089x | +6331.58% |
| 1992-12-31 | $70.40 Million | $-100.00K | -0.001x | -101.18% |
| 1991-12-31 | $31.50 Million | $3.80 Million | 0.121x | -- |
About IDEXX Laboratories Inc
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It offers in-clinic chemistry, blood and urine chemistry, he… Read more